Legacy Devers Eye Institute

Legacy Devers Eye Institute
not-for-profit healthcare,
not-for-profit research
Industry Healthcare
Founded 1959
Founder Arthur Devers
Headquarters Portland, Oregon

The Legacy Devers Eye Institute in Portland, Oregon, is one of the few private, non-profit centers for ophthalmological care, research, and training in the United States.[1] The Institute is affiliated with Legacy Health, a network of seven hospitals in Portland and Southwest Washington.[2]

Mission

The Institute offers fee-for-service and charitable eye care.[1] Part of its mission is to provide universal eye care in the Portland, Oregon, area.

The Institute also trains post-graduate professionals and conducts research. Scientists from Devers have refined how to interpret visual field testing,[3] a standard part of the assessment of glaucoma. They have also improved corneal transplantation through innovations in DLEK (deep lamellar endothelial keratoplasty)[4] and DSEK (Descemet's stripping with endothelial keratoplasty).[5]

History and Funding

The Devers Eye Institute was founded in 1959 thanks to a million-dollar bequest from Arthur Devers, a coffee merchant who suffered from retinal degeneration.[1][6] The Institute now has an endowment of approximately twenty-five million dollars held primarily by the Legacy Health Good Samaritan Foundation. Part of its research activity is supported through grants from the National Institutes of Health.

Staff and Alumni

The Devers Eye Institute staff includes fourteen ophthalmologists, four physician fellows, two clinical optometrists, and four additional senior scientists performing research. The Discoveries in Sight Research Laboratory is headed by Claude Burgoyne, M.D., 2015 winner of the American Glaucoma Society Clinician Scientist Award.[7] The clinics are directed by Steve Mansberger, M.D., M.P.H., epidemiology section editor for the American Journal of Ophthalmology.[8] The cornea service is headed by Mark Terry, M.D., 2016 recipient of the Eye Bank Association of America R. Townley Paton Award.[9] James T. Rosenbaum, M.D., is the Chief of Ophthalmology.

Notable former staff and graduates of the training program include—

References

  1. 1 2 3 "Legacy Devers Eye Institute". Oregon Lions Sight and Hearing Foundation. Retrieved 23 January 2016.
  2. "Devers Memorial Eye Clinic". Legacy Health. Retrieved 23 January 2016.
  3. L. Deng; S. Demirel; S.K. Gardiner (June 2014). "Reducing variability in visual field assessment through filtering that combines structural and functional information". Invest. Ophthal. Vis. Sci. 13: 13813.
  4. "Endothelial Keratoplasty: From DLEK to DMEK". nih.gov. (mentioning the work of Devers ophthalmologist Mark Terry)
  5. "DSEK Pearls from Mark Terry, M.D.". ophthalmologyweb.com. 28 May 2008.
  6. Rumler, J. (January 2014). "Renowned Devers Eye Institute Expands". The Scribe. Portland, Oregon: Medical Society of Metropolitan Portland. 32 (1): 1.
  7. Rumler, J. (March 2015). "Devers researchers in national spotlight". The Scribe. Portland, Oregon: Medical Society of Metropolitan Portland. 33 (3): 1.
  8. "Editors biographies". American Journal of Ophthalmology. Retrieved 19 March 2016.
  9. "R. Townley Paton Award". Eye Bank Association of America. Retrieved 19 March 2016.
  10. "UAB - SOM - Dept of Ophthalmology - J. Crawford Downs, Ph.D.". uab.edu.
  11. "Laboratory of Ocular Biomechanics". ocularbiomechanics.com.
  12. "Baylor College of Medicine Appoints Dr. Timothy Stout Chair Of Ophthalmology". BioNews Texas.
  13. Samanlego, Chiles Aedam R. (29 April 2014). "New therapeutic dimensions in corneal transplantation". Eyeworld Daily News. p. 20. Retrieved 6 February 2016.
  14. Boyle, Erin L. (February 2014). "DMEK experts offer pearls, pitfalls for performing procedure". Eyeworld. Retrieved 6 February 2016.
  15. "Dr. Peter Veldman; Cornea". Massachusetts Eye and Ear.
  16. "Peter B. Veldman, M.D.". Harvard Medical School Department of Ophthalmology.
This article is issued from Wikipedia - version of the 6/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.